Source: Annual Congress 2002 - Cough and sleep apnoea
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
P. Cebollero, J. A. Cascante, J. Abú, J. Boldú, V. M. Egua, J. Hueto (Pamplona, Spain). Associated pathologies and tobacco habit in patients diagnosed of obstructive sleep apnoea syndrome treated with nCPAP. Eur Respir J 2002; 20: Suppl. 38, 2860

Member's Comments

No comment yet.

Related content which might interest you: Treatment control in risk patients with obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 411s Year: 2006 Compliance with CPAP/BiPAP treatment in obstructive sleep apnea syndrome patients Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010 Investigation of the prevalence of obstructive sleep apnea syndrome in patients with diagnosed subclinicalhypothyroidism Source: Sleep and Breathing Conference 2021 Year: 2021 Compliance with nCPAP in elderly patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2004; 24: Suppl. 48, 569s Year: 2004 Severe obstructive sleep apnea patients and smoking cessation Source: Annual Congress 2009 - Clinical aspects of sleep apnoea Year: 2009 Unrecognised hypertension in patients screened for obstructive sleep apnoea Source: Eur Respir J 2005; 26: Suppl. 49, 40s Year: 2005 The influence of obesity in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 295s Year: 2002 Prevalence of very severe obstructive sleep apnea syndrome from symptomatic patients. Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea Year: 2019 Should patients with obstructive sleep apnea syndrome be screened for hypothyroidism? Source: Eur Respir J 2005; 26: Suppl. 49, 569s Year: 2005 Prevalence of metabolic syndrome in patients with hypertension and obstructive sleep apnea Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009 Perennial allergies in patients treated with nCPAP for obstructive sleep apnoea Source: Eur Respir J 2001; 18: Suppl. 33, 216s Year: 2001 Possibility of treating patients with obstructive sleep apnea syndrome and nocturnal asystoles using CPAP therapy Source: Annual Congress 2009 - Clinical aspects of sleep apnoea Year: 2009 Enuresis in obstructive sleep apnea syndrome patients Source: Annual Congress 2012 - Sleep apnoea: clinical topics Year: 2012 Comorbidities of obstructive sleep apnoea syndrome Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities Year: 2011 ME1 Treating obstructive sleep apnoea syndrome in children Source: Milan 2017 - Educational material Year: 2017 PAI-uPA system in patients with obstructive sleep apnea syndrome (OSAS) in CPAP treatment Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing Year: 2012 Effects of CPAP treatment on physical fitness in patients with obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2003; 22: Suppl. 45, 97s Year: 2003 The symptom prevalence of obstructive sleep apnea syndrome in patients with asthma and COPD Source: Eur Respir J 2006; 28: Suppl. 50, 198s Year: 2006 The prevalence of unrecognized obstructive sleep apnea syndrome among patients with nocturnal symptoms and poorly controlled asthma Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities Year: 2017 Prevalence of obstructive sleep apnea in patients with difficult-to-treat asthma Source: Annual Congress 2011 - Asthma: risk factors and comorbidities Year: 2011